<DOC>
	<DOCNO>NCT01308749</DOCNO>
	<brief_summary>The investigator propose conduct pilot study evaluate oxytocin supplemental treatment improve social difficulty individual autism .</brief_summary>
	<brief_title>A Study Oxytocin Children Adolescents With Autistic Disorder</brief_title>
	<detailed_description>The propose pilot study essential first step toward rigorously evaluate oxytocin treatment individual autism . The biologic action oxytocin social cognition prosocial behavior clinical , genetic epigenetic evidence involvement oxytocin system pathophysiology case autism strongly suggest supplemental oxytocin therapy could significantly improve social disability involve autism . Many people feel social difficulty characteristic central feature autism . Overall , study aim determine tolerability , accessibility , feasibility oxytocin pilot study . This study consent 30 subject order randomize 25 subject 2-month ( 8 week ) randomize double-blind , placebo-controlled initial treatment period , subsequent 2-month ( 8 week ) period participant receive oxytocin , three post-treatment visit occur week 28 ( Â±2 week ) , interim visit anytime week 16 week 76 patient plan start oxytocin outside study treatment experience lag time week 16 ( end open label treatment ) outside oxytocin treatment begin , time week 76 . The investigator hope study help inform future study design determine whether short term long term treatment trial necessary observe significant effect . This also help develop systematic preliminary safety measure .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Between 3 17 year old , inclusive . Have clinical diagnosis autistic disorder confirm accord DSMIV criterion use Autism Diagnostic Interview Revised ( ADIR ) and/or Autism Diagnostic Observation Scale ( ADOS , Lord et al. , 1989 ) . Changes ally health therapy , behavioral educational intervention within past 2 month baseline visit associate school holiday . Changes psychotropic alternative medication dos last 30 day baseline visit . Subjects medical condition might interfere conduct study , confound interpretation study result , endanger wellbeing . This include , limited , Rett Syndrome , impairment renal function , evidence history malignancy significant hematological , endocrine , cardiovascular ( include rhythm disorder uncontrolled hypertension ) , respiratory , hepatic , gastrointestinal disease . Marked sensory impairment deafness blindness would interfere conduct study . Pregnancy/Nursing unknown effect oxytocin unborn baby and/or nurse infant . All female childbearing potential administer urine serum pregnancy test screen point study physician discretion . Refusal undergo pregnancy test result exclusion study . The investigator share result pregnancy test subject 's legal guardian . Refusal practice contraception sexually active effect exposure high concentration oxytocin sperm newly conceive embryos unknown . Sexually active men woman take part study partner use effective birth control method ( example , woman use birth control pill , intrauterine device [ IUD ] diaphragm men use condom ) . Inability caretaker speak English . Absence consistent caretaker report symptom . Subjects , Investigator 's opinion , might suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>